DP VII Associates L.P., 10% Owner at Evoke Pharma Inc (EVOK), sold 82 shares at $5.20 ($415) on 2016-04-25, disclosed to the SEC on 2016-04-27.
Open-market sale of $415 EVOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 21 | $109 | 26.3% |
| 2 | $5.02 | 61 | $306 | 73.7% |
| Total | $5.07 avg | 82 | $415 | 100% |
| Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |
| CADX | SELL | 2013-02-01 | $2K | — | Filing → |